Mortality from asthma and bronchodilator aerosols
- PMID: 1272120
Mortality from asthma and bronchodilator aerosols
Abstract
The mortality rate from asthma in Australia had a transcient rise between 1960 to 1967. There was a remarkably high correlation between the sales of pressurized adrenergic aerosols in each of the four most populated States and the corresponding asthma mortality rate for two triennia, 1961 to 1963 and 1964 to 1966. This relationship was not found after 1966. From 1965 to 1966, Australians were warned repeatedly of the possible dangers of over-usage of the adrenergic aerosols. The sales pattern of the aerosols altered, showing a slackening of the rate of increase of sales in 1966 and 1967. This and other evidence suggests that the warnings may have reduced the prevalence of over-usage of the aerosols and that before this, over-usage of the adrenergic aerosols could have caused the epidemic of asthma deaths.
Similar articles
-
Metaproterenol, a new bronchodilator:: comparison with isoproterenol.Am J Med Sci. 1967 Mar;253(3):321-4. Am J Med Sci. 1967. PMID: 6021691 No abstract available.
-
Beta adrenergic stimulant aerosols in bronchial asthma: an assessment.Indian J Chest Dis. 1973 Apr;15(2):123-31. Indian J Chest Dis. 1973. PMID: 4580542 Clinical Trial. No abstract available.
-
A crossover comparison of isoproterenol, metaproterenol and isoetharine by spirometric determinations.Ann Allergy. 1967 Sep;25(9):512-9. Ann Allergy. 1967. PMID: 4861327 Clinical Trial. No abstract available.
-
[Overdosed aerosols and mortality of bronchial asthma].Lijec Vjesn. 1969 Aug;91(8):900-3. Lijec Vjesn. 1969. PMID: 4910068 Review. Croatian. No abstract available.
-
Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs.Ann Allergy. 1994 Nov;73(5):439-43. Ann Allergy. 1994. PMID: 7978538 Review.
Cited by
-
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.Thorax. 1982 Apr;37(4):280-7. doi: 10.1136/thx.37.4.280. Thorax. 1982. PMID: 7112457 Free PMC article.
-
Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.Cochrane Database Syst Rev. 2000;2003(4):CD001285. doi: 10.1002/14651858.CD001285. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(2):CD001285. doi: 10.1002/14651858.CD001285. PMID: 11034709 Free PMC article. Updated.
-
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.Cochrane Database Syst Rev. 2002;2002(4):CD003901. doi: 10.1002/14651858.CD003901. Cochrane Database Syst Rev. 2002. PMID: 12519616 Free PMC article.
-
Current issues with beta2-adrenoceptor agonists: historical background.Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):107-18. doi: 10.1385/CRIAI:31:2:107. Clin Rev Allergy Immunol. 2006. PMID: 17085787
-
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001385. doi: 10.1002/14651858.CD001385.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253458 Free PMC article.